Copy Link Print Information

Simridarlimab

(Synonyms: IBI-322)
Avis client

Based on 1 Customer Validation

Simridarlimab (IBI-322) is a bispecific antibody targeting PD-L1 and CD47. Simridarlimab attenuates CD47 activity in monovalent binding and blockes PD-L1 activity in bivalent binding. Simridarlimab selectively binds to CD47+PD-L1+ tumor cells, effectively inhibits CD47-SIRPα signal and triggered strong tumor cell phagocytosis in vitro.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

  • Pureté: 99.81%
  • CAS No.: 2378862-90-7
  • Masse moléculaire:125.734 kDa
  • Stockage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Simridarlimab
  • Experimental Validation Results for Simridarlimab
  • Experimental Validation Results for Simridarlimab
  • Experimental Validation Results for Simridarlimab
  • Simridarlimab Chemical Structure
    Simridarlimab Chemical Structure
CAS No.: 2378862-90-7
Size
Prix
Stock
Quantité
Amount: USD 0.00
Please select quantity
or
or

* Veuillez sélectionner la quantité avant d'ajouter des articles.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Simridarlimab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Trouvez votre distributeur local Your local distributor: Hycultec GmbHHycultec
  • Activité biologique
  • Chemical Information
  • Pureté et documentation
  • Références
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products
Keywords
MOQ
Minimum order quantity
100 mg

Obtenir un devis En stock

Other size
Obtenir un devis
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Enregistrer
Sign in to MedChemExpress
Enregistrer un nouveau compte

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    (G1_L-kappa)_VH-VH-h-CH2-CH3

  • 1/16

    Immobilized CD47 Protein, Human (HEK293, HY-P72917) can bind Simridarlimab. The EC50 for this effect is 134.7 ng/mL.

  • 1/16

    Immobilized PD-L1 Protein, Human (HEK293, HY-P73361) can bind Simridarlimab. The EC50 for this effect is 188.8 ng/mL.

  • 1/16

    Flow cytometric analysis of 1×106 Jurkat cells labelling CD47 (red) with Simridarlimab (HY-P99903). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Alexa Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa Isotype Control (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).

  • Simridarlimab Chemical Structure
    1/16
  • Simridarlimab
  • Immobilized CD47 Protein, Human (HEK293, HY-P72917) can bind Simridarlimab. The EC50 for this effect is 134.7 ng/mL.
  • Immobilized PD-L1 Protein, Human (HEK293, HY-P73361) can bind Simridarlimab. The EC50 for this effect is 188.8 ng/mL.
  • Flow cytometric analysis of 1×106 Jurkat cells labelling CD47 (red) with Simridarlimab (HY-P99903). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Alexa Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa Isotype Control (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
  • (G1_L-kappa)_VH-VH-h-CH2-CH3